Immune cell receptors and signaling pathways

Immune cell receptors and signaling pathways represent a vast and diverse collection of molecular components that coordinate the body's defense against pathogens and internal threats. These systems include cell-surface receptors such as T-cell receptors (TCRs), B-cell receptors (BCRs), Toll-like receptors (TLRs), and cytokine receptors, which detect specific antigens or molecular patterns (Janeway's Immunobiology, 9th Ed). Upon activation, these receptors initiate complex intracellular signaling cascades, often involving phosphorylation events mediated by kinases like Janus kinases (JAK) or the activation of transcription factors like NF-kappaB (StatPearls, "Physiology, Immune Response"). In healthy states, these pathways maintain immune homeostasis and effective response; however, their dysregulation is a primary driver of autoimmune disorders, chronic inflammation, and various malignancies (Nature Reviews Immunology, "Signaling in the immune system"). Pharmacological targeting of these pathways is a cornerstone of modern medicine, utilizing monoclonal antibodies to block inhibitory checkpoints (e.g., PD-1/PD-L1) or small molecules to inhibit specific signaling nodes (e.g., JAK inhibitors) (NCBI, "Targeted Therapy in Autoimmune Diseases"). Because these pathways are integral to host defense, therapeutic modulation carries significant risks, including systemic immunosuppression and cytokine release syndrome (PubMed, "Safety of Immunotherapy").

Other names

Immune signalingLeukocyte receptorsImmunological synapse componentsCytokine signaling pathways

Modulation of immune cell activation through receptor blockade, ligand sequestration, or intracellular kinase inhibition.